AAAAAA
Results:
1-14
|
Results: 14
Authors:
Gissmann, L
Osen, W
Muller, M
Jochmus, I
Citation: L. Gissmann et al., Therapeutic vaccines for human papillomaviruses, INTERVIROLO, 44(2-3), 2001, pp. 167-175
Authors:
Osen, W
Peiler, T
Ohlschlager, P
Caldeira, S
Faath, S
Michel, N
Muller, M
Tommasino, M
Jochmus, I
Gissmann, L
Citation: W. Osen et al., A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity, VACCINE, 19(30), 2001, pp. 4276-4286
Authors:
Zehbe, I
Tachezy, R
Mytilineos, J
Voglino, G
Mikyskova, I
Delius, H
Marongiu, A
Gissmann, L
Wilander, E
Tommasino, M
Citation: I. Zehbe et al., Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes, INT J CANC, 94(5), 2001, pp. 711-716
Authors:
Kaufmann, AM
Nieland, J
Schinz, M
Nonn, M
Gabelsberger, J
Meissner, H
Muller, RT
Jochmus, I
Gissmann, L
Schneider, A
Durst, M
Citation: Am. Kaufmann et al., HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination, INT J CANC, 92(2), 2001, pp. 285-293
Authors:
Osen, W
Jochmus, I
Muller, M
Gissmann, L
Citation: W. Osen et al., Immunization against human papillomavirus infection and associated neoplasia, J CLIN VIRO, 19(1-2), 2000, pp. 75-78
Authors:
Rossi, JL
Gissmann, L
Jansen, K
Muller, M
Citation: Jl. Rossi et al., Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae, HUM GENE TH, 11(8), 2000, pp. 1165-1176
Authors:
Schreckenberger, C
Sethupathi, P
Kanjanahaluethai, A
Muller, M
Zhou, J
Gissmann, L
Qiao, L
Citation: C. Schreckenberger et al., Induction of an HPV 6bL1-specific mucosal IgA response by DNA immunization, VACCINE, 19(2-3), 2000, pp. 227-233
Authors:
Kaufmann, AM
Gissmann, L
Simms, P
Schreckenberger, C
Qiao, L
Citation: Am. Kaufmann et al., Comparison of cytokines and CD80 for enhancement of immunogenicity of cervical cancer cells, IMMUNOBIOL, 202(4), 2000, pp. 339-352
Authors:
Venturini, F
Braspenning, J
Homann, M
Gissmann, L
Sczakiel, G
Citation: F. Venturini et al., Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells, NUCL ACID R, 27(7), 1999, pp. 1585-1592
Authors:
Borchers, A
Braspenning, J
Meijer, J
Osen, W
Gissmann, L
Jochmus, I
Citation: A. Borchers et al., E7-specific cytotoxic T cell tolerance in HPV-transgenic mice, ARCH VIROL, 144(8), 1999, pp. 1539-1556
Authors:
Jochmus, I
Schafer, K
Faath, S
Muller, M
Gissmann, L
Citation: I. Jochmus et al., Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16)as a prophylactic and therapeutic vaccine, ARCH MED R, 30(4), 1999, pp. 269-274
Authors:
Schenkel, J
Gaissert, H
Protopapa, EE
Weiher, H
Gissmann, L
Alonso, A
Citation: J. Schenkel et al., The human papillomavirus type 11 upstream regulatory region triggers hair-follicle-specific gene expression in transgenic mice, J INVES DER, 112(6), 1999, pp. 893-898
Authors:
Schafer, K
Muller, M
Faath, S
Henn, A
Osen, W
Zentgraf, H
Benner, A
Gissmann, L
Jochmus, I
Citation: K. Schafer et al., Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: Induction of cytotoxic T cells and specific tumor protection, INT J CANC, 81(6), 1999, pp. 881-888
Authors:
Schneider, A
Durst, M
Jochmus, I
Gissmann, L
Citation: A. Schneider et al., Epidemiology, aetiology and prevention of carcinoma of the cervix, GYNAKOLOGE, 32(4), 1999, pp. 247-260
Risultati:
1-14
|